No releases bombesin-like immunoreactivity from enteric synaptosomes by cross-activation of protein kinase A

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 6 39-6, 1999, Pages

  Kurjak, M ^a   Fritsch, R ^a   Saur, D ^a   Schusdziarra, V ^a   Allescher, H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Enteric nervous system; Gastrin releasing peptide; Nerve terminals; Nitric oxide; Phosphodiesterase 3; Phosphodiesterase 5

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BOMBESIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; CYCLIC GMP; CYCLIC GMP DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; OXYHEMOGLOBIN; PHOSPHODIESTERASE; TREQUINSIN;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; IMMUNOREACTIVITY; INTESTINE INNERVATION; INTESTINE MOTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SYNAPTOSOME;

EID: 0033002087     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.6.g1521     Document Type: Article

References (44)

1. Allescher, H. D., M. Kurjak, A. Huber, P. Trudrung, and V. Schusdziarra. Regulation of VIP release from rat enteric nerve terminals: evidence for a stimulatory effect of NO. Am. J. Physiol. 271 (Gastrointest. Liver Physiol. 34): G568-G574, 1996.
2. Barbier, A. J., and R. A. Lefebvre. Relaxant influence of phosphodiesterase inhibitors in the cat gastric fundus. Eur. J. Pharmacol. 276: 41-47, 1995.
3. Beavo, J. A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75: 725-748, 1995.
4. Beltman, J., D. E. Becker, E. Butt, G. S. Jensen, S. D. Rybalkin, B. Jastorff, and J. A. Beavo. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains. Mol. Pharmacol. 47: 330-339, 1995.
5. Bradford, M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72; 248-254, 1976.
6. Butt, E., J. Beltman, D. E. Becker, G. S. Jensen, S. D. Rybalkin, B. Jastorff, and J. A. Beavo. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins. Mol. Pharmacol. 47; 340-347, 1995.
7. Butt, E., M. Eigenthaler, and H.-G. Genieser. (Rp)-8-pCPTS, a novel cGMP-dependent proteinkinase inhibitor. Eur. J. Pharmacol. 269; 265-268, 1994.
8. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
9. Costa, M., S. J. Brookes, S. Waterman, and R. Mayo. Enteric neuronal circuitry and transmitters controlling intestinal motor function. In: Advances in the Innervation of the Gastrointestinal Tract, edited by G. E. Holle and J. D. Wood. Amsterdam: Elsevier Science, 1992, p. 115-124.
10. Degerman, E., P. Belfrage, and V. C. Manganiello. cGMP-inhibited phosphodiesterases (PDE 3 family). Biochem. Soc. Trans. 24: 1010-1014, 1996.
11. Dostmann, W. R. (Rp)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition. FEBS Lett. 375: 231-234, 1995.
12. Garthwaite, J., E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt, and B. Mayer. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-(1,2,4,)oxadiazolo(4,3,-a)quinoxalin-1-one. Mol. Pharmacol. 48: 184-188, 1995.
13. Gibson, Q. H., and F. J. W. Roughton. The kinetics and equilibria of the reactions of nitric oxide with sheep hemoglobin. J. Physiol. (Lond.) 136: 507-526, 1957.
14. Girard, F., H. Bachelard, S. St. Pierre, and F. Rioux. The contractile effect of bombesin, gastrin releasing peptide and various fragments in the rat stomach strip. Eur. J. Pharmacol. 102: 489-497, 1984.
15. Grider, J. R., and J. G. Jin. Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 54: 521-526, 1993.
16. Griess, J. P. On a new series of bodies in which nitrogen is substituted for hydrogen. Philos. Trans. R. Soc. Lond. B Biol. Sci. 154: 667-731, 1864.
17. Hebeiss, K., and H. Kilbinger. Differential effects of nitric oxide donors on basal and electrically evoked release of acetylcholine from guinea-pig myenteric neurones. Br. J. Pharmacol. 118: 2073-2078, 1996.
18. Hebeiss, K., and H. Kilbinger. Nitric oxide-sensitive guanylyl cyclase inhibits acetylcholine release and excitatory motor transmission in the guinea-pig ileum. Neuroscience 82: 623-629, 1998.
19. Hryhorenko, L. M., Z. Woskowska, and J. E. Fox-Threlkeld. Nitric oxide inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: relationship to motility and release of NO. J. Pharmacol. Exp. Ther. 271: 918-926, 1994.
20. Huber, A., P. Trudrung, M. Storr, H. Franck, V. Schusdziarra, P. Ruth, and H. D. Allescher. Protein kinase G expression in the small intestine and functional importance for smooth muscle relaxation. Am. J. Physiol. 275 (Gastrointest. Liver Physiol. 38): G629-G637, 1998.
21. Jiang, H., J. B. Shabb, and J. D. Corbin. Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissues. Biochem. Cell Biol. 70: 1283-1289, 1992.
22. Kamisaki, Y., K. Wada, K. Nakamoto, and T. Itoh. Nitric oxide inhibition of depolarization evoked glutamate release from synaptosomes of rat cerebellum. Neurosci. Lett. 194: 5-8, 1995.
23. Knowles, R. G., M. Palacios, J. Palmer, and S. Moncada. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86: 5159-5162, 1992.
24. Kostka, P., E. Jang, E. G. Watson, J. Steward, and E. E. Daniel. Nitric oxide synthase in the autonomic nervous system of canine ileum. J. Pharmacol. Exp. Ther. 264: 234-239, 1993.
25. Kotera, J., N. Yanaka, K. Fujishige, Y. Imai, H. Akatsuka, T. Ishizuka, K. Kawashima, and K. Omori. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur. J. Biochem. 249: 434-442, 1997.
26. Kurjak, M., H. D. Allescher, V. Schusdziarra, and M. Classen. Release of bombesin-like immunoreactivity from synaptosomes isolated from the rat ileum. Eur. J. Pharmacol. 257: 169-179, 1994.
27. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. Landgraf, W., R. Hullin, and F. Hofmann. Phosphorylation of cGMP-dependent protein kinase increases the affinity for cyclic AMP. Eur. J. Biochem. 154: 113-117, 1986.
29. Loughney, K., T. R. Hill, F. V. A. Florio, L. Uher, G. J. Rosman, S. L. Wolda, B. A. Jones, M. L. Howard, L. McAllister-Lucas, W. K. Sonnenburg, S. H. Francis, J. D. Corbin, J.A. Beavo, and K. Ferguson. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 216: 139-147, 1998.
30. Murthy, K. S., and G. M. Makhlouf. Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am. J. Physiol. 268 (Cell Physiol. 37): C171-C180, 1995.
31. 3H]GABA release from cerebral cortical neurons is mediated by peroxynitrite. J. Neurochem. 65: 1109-1114, 1995.
32. Pradelles, P., and J. Grassi. Enzyme immunoassays of adenosin cyclic 3′,5′-monophosphate and guanosin cyclic 3′,5′-monophosphate using acetylcholinesterase. Anal. Chem. 61: 447-451, 1989.
33. Pyne, N. J., V. Arshavsky, and A. Lochhead. cGMP signal termination. Biochem. Soc. Trans. 24: 1019-1022, 1996.
34. Ruppert, D., and K. U. Weithmann. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro. Life Sci. 31: 2037-2043, 1982.
35. Schmidt, H. H., G. D. Gagne, M. Nakane, J. S. Pollock, M. F. Miller, and F. Murad. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitritergic signal transduction. J. Histochem. Cytochem. 40: 1439-1456, 1992.
36. Schmidt, H. H. W., S. M. Lohmann, and U. Walter. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1178: 153-175, 1993.
37. Schmidt, H. H. H. W., T. D. Warner, M. Nakane, U. Förstermann, and F. Murad. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41: 615-624, 1992.
38. Schusdziarra, V., H. Bender, and E. F. Pfeiffer. Release of bombesin like immunoreactivity from the isolated perfused rat stomach. Regul. Pept. 7: 21-29, 1983.
39. Sette, C., E. Vicini, and M. Conti. The rat PDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J. Biol. Chem. 269: 18271-18274, 1994.
40. Uemura, S., S. Pompolo, and J. B. Furness. Colocalization of neuropeptide Y with other neurochemical markers in the guinea-pig small intestine. Arch. Histol. Cytol. 58: 523-536, 1995.
41. Wang, X., and P. J. Robinson. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68: 443-456, 1997.
42. Wroblewski, F., and J. S. Ladue. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90: 210-212, 1955.
43. Xia, Y., V. L. Dawson, T. M. Dawson, S. H. Snyder, and J. L. Zweier. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA 93: 6770-6774, 1996.
44. Zettler, G. Antagonism of cholecystokinin-like peptides by opioid peptides, morphine or tetrodotoxin. Eur. J. Pharmacol. 60: 67-77, 1979.